跳至主要内容
临床试验/CTIS2023-506803-25-01
CTIS2023-506803-25-01进行中(未招募)1 期

AntaMIn - Pain reduction for limb injuries in pediatric emergency departments: A Randomised Clinical Trial comparing intranasal Fentanyl or intranasal Ketamine to oral morphine - APHP211044

Assistance Publique Hopitaux De Paris0 个研究点目标入组 300 人开始时间: 2024年4月18日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 17(—)
性别
All

入选标准

  • 1)Child aged 2 years to 17 years and 11 months, With 10 kg = Weight = 100 kg, Presenting to ED with a traumatic pain and suspected fracture(s) based on an acute deformity AND experiencing pain and / or functional impotence in the injured limb(s), Within the first 12 hours after the injury, VAS pain score at ED arrival = 60/100 (if child = 7) or Evendol pain score at ED arrival = 7/15 (if child <7 years), Affiliated to health insurance, At least one signed parental informed consent

排除标准

  • Received narcotic pain medication prior to arrival, Contraindication to fentanyl or ketamine, mentioned in SmPC, GCS <15, Evidence of significant femur, head, chest, abdominal, or spine injury, Open fracture, Nasal trauma or complete nasal obstruction, Active epistaxis, Nasal or sinus surgery within 6 months before inclusion, History of high blood pressure, known coronary artery disease, congestive heart failure, acute glaucoma, increased intracranial pressure, , hepatocellular insufficiency, Active or history of psychiatric disorder, Known pregnancy or suspicion of being pregnant, Breastfeeding, Non-French speaking parent and / or child., Participation to another interventional clinical research, Contraindication to morphine, mentioned in SmPC, Hypersensitivity to ketamine or fentanyl or to excipients (sodium chloride, sodium hydroxide), or to other opioids.

研究者

相似试验